A pilot study assessing the incidence and clinical significance of circulating tumor cells in esophagogastric cancers

Clinical Colorectal Cancer

Volumn 13, Issue 2, 2014, Pages 94-99

  Sclafani, Francesco ^a   Smyth, Elizabeth ^a   Cunningham, David ^a   Chau, Ian ^a   Turner, Andrea ^a   Watkins, David ^a  

^a ROYAL MARSDEN HOSPITAL   (United Kingdom)

Author keywords

Biomarkers; Chemotherapy; CTCs; Esophageal cancer; Gastric cancer

Indexed keywords

CAPECITABINE; EPIRUBICIN; OXALIPLATIN; PANITUMUMAB;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BLOOD SAMPLING; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER INCIDENCE; CANCER SURVIVAL; CIRCULATING TUMOR CELL; CLINICAL ARTICLE; CONTROLLED STUDY; ESOPHAGEAL ADENOCARCINOMA; FEMALE; HUMAN; LIVER METASTASIS; LYMPH NODE METASTASIS; MALE; MULTIPLE CYCLE TREATMENT; OVERALL SURVIVAL; PERITONEUM METASTASIS; PREVALENCE; PROGRESSION FREE SURVIVAL; STOMACH ADENOCARCINOMA; TREATMENT RESPONSE; ADENOCARCINOMA; CLINICAL TRIAL; DISEASE FREE SURVIVAL; ESOPHAGEAL NEOPLASMS; INCIDENCE; METABOLISM; METASTASIS; MIDDLE AGED; PATHOLOGY; PILOT STUDY; PROGNOSIS; PROSPECTIVE STUDY; STOMACH NEOPLASMS; SURVIVAL RATE; TREATMENT OUTCOME; TUMOR EMBOLISM;

ADENOCARCINOMA; ADULT; AGED; DISEASE-FREE SURVIVAL; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASTIC CELLS, CIRCULATING; PILOT PROJECTS; PREVALENCE; PROGNOSIS; PROSPECTIVE STUDIES; STOMACH NEOPLASMS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84900481655     PISSN: 15330028     EISSN: 19380674     Source Type: Journal    
DOI: 10.1016/j.clcc.2013.11.003     Document Type: Article

References (49)

1. D. Gonzalez de Castro, P.A. Clarke, and B. Al-Lazikani et al. Personalized cancer medicine: molecular diagnostics, predictive biomarkers, and drug resistance Clin Pharmacol Ther 93 2013 252 259
2. R.F. Alexander, and A.I. Spriggs The differential diagnosis of tumour cells in circulating blood J Clin Pathol 13 1960 414 424
3. M. Cristofanilli, G.T. Budd, and M.J. Ellis et al. Circulating tumor cells, disease progression, and survival in metastatic breast cancer N Engl J Med 351 2004 781 791
4. A. Lucci, C.S. Hall, and A.K. Lodhi et al. Circulating tumour cells in non-metastatic breast cancer: a prospective study Lancet Oncol 13 2012 688 695
5. M.G. Krebs, R. Sloane, and L. Priest et al. Evaluation and prognostic significance of circulating tumor cells in patients with non-small-cell lung cancer J Clin Oncol 29 2011 1556 1563
6. H. Iinuma, T. Watanabe, and K. Mimori et al. Clinical significance of circulating tumor cells, including cancer stem-like cells, in peripheral blood for recurrence and prognosis in patients with Dukes' stage B and C colorectal cancer J Clin Oncol 29 2011 1547 1555
7. H.I. Scher, X. Jia, and J.S. de Bono et al. Circulating tumour cells as prognostic markers in progressive, castration-resistant prostate cancer: a reanalysis of IMMC38 trial data Lancet Oncol 10 2009 233 239
8. E.A. Punnoose, S.K. Atwal, and J.M. Spoerke et al. Molecular biomarker analyses using circulating tumor cells PLoS One 5 2010 e12517
9. G.M. Cann, Z.G. Gulzar, and S. Cooper et al. mRNA-Seq of single prostate cancer circulating tumor cells reveals recapitulation of gene expression and pathways found in prostate cancer PLoS One 7 2012 e49144
10. M. Yu, A. Bardia, and B.S. Wittner et al. Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition Science 339 2013 580 584
11. S.-J. Dawson, D.W.Y. Tsui, and M. Murtaza et al. Analysis of circulating tumor DNA to monitor metastatic breast cancer N Engl J Med 368 2013 1199 1209
12. I. Vogel, and H. Kalthoff Disseminated tumour cells: their detection and significance for prognosis of gastrointestinal and pancreatic carcinomas Virchows Arch 439 2001 109 117
13. J.M. Gasent Blesa, V. Alberola Candel, and E. Esteban González et al. Circulating tumor cells in breast cancer: methodology and clinical repercussions Clin Transl Oncol 10 2008 399 406
14. Y.F. Sun, X.R. Yang, and J. Zhou et al. Circulating tumor cells: advances in detection methods, biological issues, and clinical relevance J Cancer Res Clin Oncol 137 2011 1151 1173
15. I. Van der Auwera, D. Peeters, and I.H. Benoy et al. Circulating tumour cell detection: a direct comparison between the CellSearch System, the AdnaTest and CK-19/mammaglobin RT-PCR in patients with metastatic breast cancer Br J Cancer 102 2010 276 284
16. W.J. Allard, J. Matera, and M.C. Miller et al. Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases Clin Cancer Res 10 2004 6897 6904
17. K.H. Yeh, Y.C. Chen, and S.H. Yeh et al. Detection of circulating cancer cells by nested reverse transcription polymerase chain reaction of cytokeratin 19 (K19) - possible clinical significance in advanced gastric cancer Anticancer Res 18 1998 1283 1286
18. S. Nakashima, S. Natsugoe, and M. Matsumoto et al. Clinical significance of circulating tumor cells in blood by molecular detection and tumor markers in esophageal cancer Surgery 133 2003 162 169
19. H. Ito, T. Kanda, and T. Nishimaki et al. Detection and quantification of circulating tumor cells in patients with esophageal cancer by real-time polymerase chain reaction J Exp Clin Cancer Res 23 2004 455 464
20. M. Ikeguchi, and N. Kaibara Detection of circulating cancer cells after a gastrectomy for gastric cancer Surg Today 35 2005 436 441
21. B. Illert, M. Fein, and C. Otto et al. Disseminated tumor cells in the blood of patients with gastric cancer are an independent predictive marker of poor prognosis Scand J Gastroenterol 40 2005 843 849
22. J.H. Seo, C.W. Choi, and B.S. Kim et al. Follow-up study of peripheral blood carcinoembryonic antigen mRNA using reverse transcription polymerase chain reaction as an early marker of clinical recurrence in patients with curatively resected gastric cancer Am J Clin Oncol 28 2005 24 29
23. Y.H. Uen, S.R. Lin, and C.H. Wu et al. Clinical significance of MUC1 and c-Met RT-PCR detection of circulating tumor cells in patients with gastric carcinoma Clin Chim Acta 367 2006 55 61
24. C.H. Wu, S.R. Lin, and J.S. Hsieh et al. Molecular detection of disseminated tumor cells in the peripheral blood of patients with gastric cancer: evaluation of their prognostic significance Dis Markers 22 2006 103 109
25. Y. Fujita, M. Terashima, and Y. Hoshino et al. Detection of cancer cells disseminated in bone marrow using real-time quantitative RT-PCR of CEA, CK19, and CK20 mRNA in patients with gastric cancer Gastric Cancer 9 2006 308 314
26. A. Pituch-Noworolska, P. Kolodziejczyk, and J. Kulig et al. Circulating tumour cells and survival of patients with gastric cancer Anticancer Res 27 2007 635 640
27. K. Mimori, T. Fukagawa, and Y. Kosaka et al. A large-scale study of MT1-MMP as a marker for isolated tumor cells in peripheral blood and bone marrow in gastric cancer cases Ann Surg Oncol 15 2008 2934 2942
28. S.M. Yie, B. Lou, and S.R. Ye et al. Detection of survivin-expressing circulating cancer cells (CCCs) in peripheral blood of patients with gastric and colorectal cancer reveals high risks of relapse Ann Surg Oncol 15 2008 3073 3082
29. S. Ishigami, A. Sakamoto, and Y. Uenosono et al. Carcinoembryonic antigen messenger RNA expression in blood can predict relapse in gastric cancer J Surg Res 148 2008 205 209
30. T. Koga, E. Tokunaga, and Y. Sumiyoshi et al. Detection of circulating gastric cancer cells in peripheral blood using real time quantitative RT-PCR Hepatogastroenterology 55 2008 1131 1135
31. K. Hiraiwa, H. Takeuchi, and H. Hasegawa et al. Clinical significance of circulating tumor cells in blood from patients with gastrointestinal cancer Ann Surg Oncol 15 2008 3092 3100
32. L. Bertazza, S. Mocellin, and A. Marchet et al. Survivin gene levels in the peripheral blood of patients with gastric cancer independently predict survival J Transl Med 7 2009 111
33. S. Matsusaka, K. Chin, and M. Ogura et al. Circulating tumor cells as a surrogate marker for determining response to chemotherapy in patients with advanced gastric cancer Cancer Sci 101 2010 1067 1071
34. H. Ito, H. Inoue, and N. Sando et al. Prognostic impact of detecting viable circulating tumour cells in gastric cancer patients using a telomerase-specific viral agent: a prospective study BMC Cancer 12 2012 346
35. K.E. Effenberger, M. Reeh, and S. Riethdorf et al. Clinical relevance of circulating tumor cells in esophageal cancer Cancer Res 72 suppl 8 2012 (abstract 4547)
36. M.A. Shah, and D.P. Kelsen Gastric cancer: a primer on the epidemiology and biology of the disease and an overview of the medical management of advanced disease J Natl Compr Canc Netw 8 2010 437 447
37. A. Ohtsu, M.A. Shah, and E. Van Cutsem et al. Bevacizumab in combination with chemotherapy as first-line therapy in advanced gastric cancer: a randomized, double-blind, placebo-controlled phase III study J Clin Oncol 29 2011 3968 3976
38. S. Riethdorf, V. Müller, and L. Zhang et al. Detection and HER2 expression of circulating tumor cells: prospective monitoring in breast cancer patients treated in the neoadjuvant GeparQuattro Trial Clin Cancer Res 16 2010 2634 2645
39. J.Y. Pierga, F.C. Bidard, and C. Mathiot et al. Circulating tumor cell detection predicts early metastatic relapse after neoadjuvant chemotherapy in large operable and locally advanced breast cancer in a phase II randomized trial Clin Cancer Res 14 2008 7004 7010
40. P.A. Davis The management of patients with gastric cancer: can west meet east? Jpn J Clin Oncol 30 2000 463
41. A. Ohtsu, S. Yoshida, and N. Saijo Disparities in gastric cancer chemotherapy between the East and West J Clin Oncol 24 2006 2188 2196
42. D. Cunningham, and Y.J. Chua East meets west in the treatment of gastric cancer N Engl J Med 357 2007 1863 1865
43. S.R. Markar, A. Karthikesalingam, and D. Jackson et al. Long-term survival after gastrectomy for cancer in randomized, controlled oncological trials: comparison between West and East [e-pub] Ann Surg Oncol 2013 Jan 24
44. B. Willipinski-Stapelfeldt, S. Riethdorf, and V. Assmann et al. Clin Cancer Res 11 2005 8006 8014
45. S.A. Joosse, and K. Pantel Biologic challenges in the detection of circulating tumor cells Cancer Res 73 2013 8 11
46. E.S. Lianidou Circulating tumor cells - new challenges ahead Clin Chem 58 2012 805 807
47. M. Tsujiura, D. Ichikawa, and S. Komatsu et al. Circulating microRNAs in plasma of patients with gastric cancers Br J Cancer 102 2010 1174 1179
48. H. Konishi, D. Ichikawa, and S. Komatsu et al. Detection of gastric cancer-associated microRNAs on microRNA microarray comparing pre- and post-operative plasma Br J Cancer 106 2012 740 747
49. M.Y. Song, K.F. Pan, and H.J. Su et al. Identification of serum microRNAs as novel noninvasive biomarkers for early detection of gastric cancer PLoS One 7 2012 e33608